Website Under Maintenance

Website Under Maintenance


Our site is down for scheduled maintenance. We are working to update our network to better provide the page you requested. We understand the inconvenience this may cause, but rest assured, we are doing everything we can to bring the site back online after our necessary updates.

Feedback

Aligos Therapeutics, Inc. - Common stock (NQ:ALGS)

9.790 +0.430 (+4.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 55,890
Open 9.210
Bid (Size) 9.510 (2)
Ask (Size) 10.00 (9)
Prev. Close 9.360
Today's Range 8.910 - 9.790
52wk Range 3.760 - 46.80
Shares Outstanding 42,940,089
Dividend Yield N/A

Performance

YTD
-75.4%
-75.4%
1 Month
-7.2%
-7.2%
3 Month
+35.8%
+35.8%
6 Month
+18.7%
+18.7%
1 Year
+13.0%
+13.0%

More News

Read More

Frequently Asked Questions

Is Aligos Therapeutics, Inc. - Common stock publicly traded?
Yes, Aligos Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Aligos Therapeutics, Inc. - Common stock trade on?
Aligos Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aligos Therapeutics, Inc. - Common stock?
The ticker symbol for Aligos Therapeutics, Inc. - Common stock is ALGS on the Nasdaq Stock Market
What is the current price of Aligos Therapeutics, Inc. - Common stock?
The current price of Aligos Therapeutics, Inc. - Common stock is 9.790
When was Aligos Therapeutics, Inc. - Common stock last traded?
The last trade of Aligos Therapeutics, Inc. - Common stock was at 09/26/25 04:00 PM ET
What is the market capitalization of Aligos Therapeutics, Inc. - Common stock?
The market capitalization of Aligos Therapeutics, Inc. - Common stock is 420.38M
How many shares of Aligos Therapeutics, Inc. - Common stock are outstanding?
Aligos Therapeutics, Inc. - Common stock has 420M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.